Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 1,502 shares at $5.95 ($9K) on 2018-12-04, disclosed to the SEC on 2018-12-06.
Open-market purchase of $9k CRVS by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |